DataKnowledgeCloudtrainingcoordination

COL P06731-1 GLY 000143 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)

Protein:

CEAM5 HUMAN

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Collection:

human proteoform glycosylation sites literature.csv

File (Entity type)

Description:Information for protein P06731-1 in the context of file GLY_000143

Creation Time:2026-03-02 19:57:27.000000

Results found

Linked to

	Label	Description
	p06731-1 197asn 197asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	CEAM5 HUMAN Protein (Entity type)	Carcinoembryonic antigen-related cell adhesion molecule 5 (precursor)
	p06731-1 246asn 246asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p06731-1 375asn 375asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p06731-1 204asn 204asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p06731-1 480asn 480asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p06731-1 152asn 152asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p06731-1 208asn 208asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p06731-1 580asn 580asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p06731-1 650asn 650asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification

Post Translational Modification

p06731-1 197asn 197asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Protein

CEAM5 HUMAN

Protein (Entity type)

Carcinoembryonic antigen-related cell adhesion molecule 5 (precursor)

Post Translational Modification

p06731-1 246asn 246asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p06731-1 375asn 375asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p06731-1 204asn 204asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p06731-1 480asn 480asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p06731-1 152asn 152asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p06731-1 208asn 208asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p06731-1 580asn 580asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p06731-1 650asn 650asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.